关于公司
- 法定名称: ABLYNX
- 注册国家: Belgium
描述:
Belgian biotechnology company at Zwijnaarde near Ghent, acquired by Sanofi in 2018, which pioneered Nanobody therapeutics - small antibody fragments - and continues as Sanofi's Nanobody research and development centre.
业务活动
生物制药产品
研究机构生物技术/生物制药公司
成品制剂
Marketing Authorization Holder
评分
(0)
(0)
(0)
(0)
(0)
评论
筛选：
排序方式：
暂无评论。
留下您的评分和评论